3 Places The Allergan Tribal Deal May Face Pushback
Allergan PLC's controversial attempt to shield patents for dry-eye drug Restasis from review at the Patent Trial and Appeal Board by making a deal with a Native American tribe has drawn...To view the full article, register now.
Already a subscriber? Click here to view full article